Cvs Health CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Dodge & Cox has reported beneficial ownership of 50,012,765 shares, representing 3.9% of CVS Health Corporation's common stock, as of June 30, 2026.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 7.51% beneficial ownership stake in CVS Health Corp.
NYSE
The Vanguard Group reported a 0% beneficial ownership in CVS Health Corp following an internal realignment, with subsidiaries now reporting separately.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 8.3% of CVS Health Corporation's common stock as of June 30, 2025.
NYSE
Capital World Investors has filed a Schedule 13G, revealing a beneficial ownership of 5.5% of CVS Health Corp.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 13 to its Schedule 13G, disclosing a 7.1% beneficial ownership stake in CVS Health Corporation as of March 31, 2025.